payers

The Perils of FDA Postmarket Studies: Why Delayed Drug Research Leaves Patients and Payers in the Dark

The regulatory framework governing modern pharmaceuticals relies heavily on a delicate balancing act: accelerating access to lifesaving therapies for vulnerable…